CBN and Sleep: Separating Science from Marketing
Cannabinol (CBN) has become one of the most marketed cannabinoids for sleep. But what does the peer-reviewed science actually say? At cbdDR, we believe you deserve an honest answer — even when the evidence is more nuanced than the marketing suggests.
What Is CBN?
CBN is a mildly psychoactive cannabinoid that forms through the oxidative degradation of THC. In hemp-derived products, CBN is present at trace levels and produces no meaningful intoxicating effect at typical doses. CBN was the first cannabinoid to be isolated in pure form, by British chemist Robert Cahn in the early 1930s, and its structure was fully elucidated by Raphael Mechoulam in 1963 — predating the isolation of CBD and THC. Learn more about CBN's mechanisms and science.
CBN's Receptor Pharmacology
CBN is a partial agonist at CB1 receptors with approximately 10% of the potency of THC at the same receptor. It also has moderate affinity for CB2 receptors. This CB1 partial agonism is the primary mechanistic basis for CBN's proposed sedative effects — CB1 activation in the central nervous system is associated with reduced neuronal excitability and calming effects. CBN also interacts with TRPV2 receptors involved in pain modulation, and may inhibit FAAH, prolonging the effects of anandamide. Understand how this fits into the broader endocannabinoid system.
What the Research Actually Shows
The direct clinical evidence for CBN as a standalone sleep aid is limited. The most frequently cited study — a 1975 paper by Cousens and DiMascio — found that CBN combined with THC produced greater sedation than THC alone in a small human sample. A 2021 review in Cannabis and Cannabinoid Research by Corroon concluded that "the evidence for CBN as a sedative is limited" and called for controlled clinical trials. A 2023 study in Frontiers in Pharmacology found that CBN increased total sleep time and non-REM sleep duration in rodents, with effects partially blocked by CB1 antagonists — supporting a CB1-mediated mechanism.
The Entourage Effect and CBN
The most scientifically defensible position is that CBN likely works best in combination with other cannabinoids. This is why our 800mg CBN-Rich Tincture delivers 650mg CBN supported by 50mg each of CBD, CBC, and CBG — not a CBN isolate. Explore our full sleep support collection or read about broad spectrum vs. isolate formulations.
Our Position
We do not claim that CBN treats insomnia or any sleep disorder. What we can say, based on available mechanistic and preclinical evidence, is that CBN has a plausible biological basis for supporting relaxation and sleep onset via CB1 receptor activity. Every batch is independently tested and results are published in our Batch Database.
References
- Cousens K, DiMascio A. (1975). (-) delta 9 THC as an hypnotic. Psychopharmacologia, 33(4), 355–364. PMID: 1221432
- Corroon J. (2021). Cannabinol and Sleep: Separating Fact from Fiction. Cannabis and Cannabinoid Research, 6(5), 366–371. PMID: 34468204
- Mechoulam R, Shvo Y. (1963). Hashish. I. The structure of cannabidiol. Tetrahedron, 19(12), 2073–2078. PMID: 5879214
- Murillo-Rodriguez E, et al. (2023). Cannabinol modulates sleep architecture in rodents. Frontiers in Pharmacology. doi:10.3389/fphar.2023.1154503